{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T02:20:57Z","timestamp":1649038857394},"reference-count":15,"publisher":"Japanese Urological Association","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn. j. urol"],"published-print":{"date-parts":[[2018,1,20]]},"DOI":"10.5980\/jpnjurol.109.35","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T22:32:20Z","timestamp":1547764340000},"page":"35-39","source":"Crossref","is-referenced-by-count":2,"title":["COMPLETE RESECTION OF URACHAL CARCINOMA WITH SIGMOID COLON INVASION AFTER FOLFOX CHEMOTHERAPY: A CASE REPORT"],"prefix":"10.5980","volume":"109","author":[{"given":"Akito","family":"Ito","sequence":"first","affiliation":[{"name":"Department of Urology, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Takata","sequence":"additional","affiliation":[{"name":"Department of Urology, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teppei","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshimoto","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Surgery, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouki","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Surgery, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuhei","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Urology, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suguru","family":"Tokiwa","sequence":"additional","affiliation":[{"name":"Division of Urology, Joban Hospital, Tokiwakai Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Tanji","sequence":"additional","affiliation":[{"name":"Kitamachi Tanji Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sugimura","sequence":"additional","affiliation":[{"name":"Department of Urology, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So","family":"Omori","sequence":"additional","affiliation":[{"name":"Department of Urology, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Obara","sequence":"additional","affiliation":[{"name":"Department of Urology, Iwate Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4001","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1) Wright JL, Porter MP, Li CI, Lange PH and Lin DW: Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer, 107, 721-728, 2006.","DOI":"10.1002\/cncr.22059"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sheldon CA, Clayman RV, Gonzelez R, Williams RD and Fraley EE: Malignant urachal lesions. J. Urol., 131, 1-8, 1984.","DOI":"10.1016\/S0022-5347(17)50167-6"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Tomita K, Tobisu KI, Kume H, Fujimoto H and Kakizoe T: Long survival with extended surgery for urachal carcinoma involving adjacent organs. J Urol, 159, 1298, 1998.","DOI":"10.1016\/S0022-5347(01)63588-2"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4) Ashley RA, Inman BA, Sebo TJ, Leibovich BC, Blute ML, Kwon ED and Zincle H: Urachal carcinoma: clinicopathologic features and long-term outcomes of an aggressive malignancy. Cancer, 107, 712-720, 2006.","DOI":"10.1002\/cncr.22060"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Bruins HM, Visser O, Pleoeg M, Hulsbergen-van de Kaa CA, Kiemeney LALM and Witjes JA: The Clinical Epidemiology of Urachal Carcinoma: Results of a Large, Population Based Study. J Urol., 188, 1102-1107, 2012.","DOI":"10.1016\/j.juro.2012.06.020"},{"key":"6","doi-asserted-by":"publisher","unstructured":"7) Kakizoe T, Matsumoto K, Andoh M, Nishio Y and Kishi K: Adenocarcinoma of urachus. Report of 7 cases and review of literature. Urology, 21, 360-366, 1983.","DOI":"10.1016\/0090-4295(83)90152-8"},{"key":"7","doi-asserted-by":"crossref","unstructured":"9) Slefker-Radtke AO, Gee J, Shen Y, Wen S, Daliani D, Millikan RE and Pisters LL: Multimodality management of urachal carcinoma: the M. D. Anderson Cancer Center experience. J. Urol., 169, 1295-1298, 2003.","DOI":"10.1097\/01.ju.0000054646.49381.01"},{"key":"8","doi-asserted-by":"crossref","unstructured":"10) Elser C, Sweet J, Cheran SK, Haider MA, Jewett M and Sridhar SS: A case of metastatic urachal adenocarcinoma treated with several different chemotherapeutic regimens. Can Urol Assoc J, 6, E27-31, 2012.","DOI":"10.5489\/cuaj.336"},{"key":"9","unstructured":"11) Tran B and McKendrick J: Metastatic urachal cancer responding to FOLFOX chemotherapy. Can J Urol, 17, 5120-5123, 2010."},{"key":"10","doi-asserted-by":"crossref","unstructured":"12) Mohile SG, Schleicher L and Petrylak DP: Treatment of metastatic urachal carcinoma in an elderly woman. Nat Clin Pract Oncol, 5, 55-58, 2008.","DOI":"10.1038\/ncponc1009"},{"key":"11","doi-asserted-by":"crossref","unstructured":"13) Szarvas T, Modos O, Niedworok C, Reis H, Szendroi A, Szasz MA and Nyirady P: Clinical, prognostic, and therapeutic aspects of urachal carcinoma-A comprensive review with meta-analysis of 1010 cases. Urol Oncol., 34, 388-398, 2016.","DOI":"10.1016\/j.urolonc.2016.04.012"},{"key":"12","doi-asserted-by":"crossref","unstructured":"16) Kim DY, Peak TY, Oh SY, Kim YB, Lee MY, Choi ZS and Suh KW: Pretreatment selection of regimen according to genetic analysis improves the efficacy of chemotherapy in the first line treatment of metastatic colorectal cancer. J. surg. Oncol., 109, 250-254, 2014.","DOI":"10.1002\/jso.23500"},{"key":"13","unstructured":"18) Park DJ, Stoehlmacher J, Zhang W, Tsao-wei DD, Groshen S and Lenz HJ: A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer. Cancer Res., 24, 8654-8658, 2001."},{"key":"14","unstructured":"19) Fink D, Nebel S, Aebl S, Zheng H, Cenni B, Nehme A, Christen RD and Howell SB: The role of DNA mismatch repair in platinum drug resistance. Cancer Res., 56, 4881-4886, 1996."},{"key":"15","doi-asserted-by":"crossref","unstructured":"20) Samimi G, Safaei R, Katano K, Holzre AK, Rochdi M, Tomoioka M, Goodman M and Howell SB: Increased expression of the copper efflux transporter ATP7A mediates resistance to cisplatin, carboplatin, and oxaliplatin in ovarian cancer cells. Clin. Cancer Res, 14, 4661-4669, 2004.","DOI":"10.1158\/1078-0432.CCR-04-0137"}],"container-title":["The Japanese Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/109\/1\/109_35\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,19]],"date-time":"2019-01-19T05:05:39Z","timestamp":1547874339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jpnjurol\/109\/1\/109_35\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,20]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.5980\/jpnjurol.109.35","relation":{},"ISSN":["0021-5287","1884-7110"],"issn-type":[{"value":"0021-5287","type":"print"},{"value":"1884-7110","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,20]]}}}